• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Cervical intraepithelial neoplasia grade 3 associated with adverse pregnancy outcomes

byNhat Hung (Benjamin) LamandHarsh Shah
February 22, 2022
in Chronic Disease, Obstetrics, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Compared to population- and sibling-matched cohorts, women previously diagnosed with cervical intraepithelial neoplasia grade 3 were more likely to have adverse pregnancy outcomes.

2. These adverse outcomes include higher risks of preterm birth, infection, and neonatal death.

Evidence Rating Level: 2 (Good)

Study Rundown: Extensive screening and prompt treatment have been standard-of-care for high-grade cervical intraepithelial neoplasia (CIN). While this strategy was well adopted, concerns of overtreatment arise since many CINs were treated without additional biopsies. This is especially pertinent in women of reproductive age since treatment involves a surgical intervention to the cervix, which could potentially affect future pregnancies. The current cohort study examined the pregnancy outcomes of women in Sweden who had previously been diagnosed and treated for CIN grade 3 (CIN 3) and compared these to their population- and sibling-matched counterparts without a prior CIN 3 diagnosis. It was observed that women with prior CIN 3 had a higher risk of adverse pregnancy outcomes, such as preterm births, chorioamnionitis, infant sepsis, and neonatal deaths, compared to the general population and their siblings. This risk difference, however, narrowed as the time of delivery passed. Since CIN 3 has always been treated in Sweden, the study could not determine how CIN treatment impacted these outcomes. Nonetheless, its results showed an association between CIN 3 and adverse pregnancy outcomes, which was independent of family factors.

Click here to read the study in Annals of Internal Medicine

Relevant Reading: Adverse Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia

In-Depth [retrospective cohort]: The article reported results from a population- and sibling-matched cohort study examining the association between CIN 3 diagnosis and pregnancy outcomes in Sweden. For the population comparison, the study examined 78,450 singletons born to women previously diagnosed and treated for CIN 3; 748,500 matched singletons born to women without previous CIN 3 history. For the sibling comparison, 23,199 singletons born to women with CIN 3 history were matched to 28,135 singletons born to their sisters without CIN 3. Match criteria included age at delivery, parity, years of education, preeclampsia status, marital status, smoking in pregnancy, and pre-pregnancy body mass index (BMI). The pregnancy outcomes of interest include preterm birth (categorized as extremely, very, or moderately), chorioamnionitis, infant sepsis, small size for gestational age, and fetal or neonatal deaths. Overall, compared to the general population women with CIN 3 history were more likely to have a preterm birth (<37 weeks) (odds ratio [OR], 2.09; 95% confidence interval [CI], 2.03 to 2.15); especially an extremely preterm birth (22-28 weeks) (OR, 3.00; 95% CI, 2.69 to 3.34). Chorioamnionitis (OR, 3.23; 95% CI, 2.89 to 3.62), infant sepsis (OR, 1.72; 95% CI, 1.60 to 1.86), neonatal death (OR, 1.83; 95% CI, 1.61 to 2.09) were also more likely in women with CIN 3 history. Comparison with matched siblings yielded similar associations. Furthermore, these associations were stronger in women with lower educational backgrounds, higher parity, and lower pre-pregnancy BMI. These elevated risks attenuated as the time of delivery passed, especially with the risk of neonatal death, suggesting that the modern more conservative CIN 3 treatment could decrease adverse pregnancy outcomes. The study noted that all CINs 3 were treated in Sweden and therefore, it could not determine the independent impact CIN 3 diagnoses and treatments had on pregnancy outcomes. These results suggested that women with a history of CIN 3 should be considered “high risk” in their pregnancies and receive appropriate management.

RELATED REPORTS

Monofilament suture does not reduce pregnancy loss compared to braided suture for cervical cerclage

Unintended pregnancy significantly associated with adverse maternal and infant health outcomes compared to intended pregnancy

Neonatal docosahexaenoic acid supplementation is associated with higher IQ scores at five years of age

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cervical intraepithelial neoplasia (CIN)early neonatal deatheducational backgroundgrade 3infectionparitypre-pregnancy BMIpreterm birth
Previous Post

Maternal BNT162b2 (Pfizer-BioNTech) COVID-19 vaccination is not associated with adverse neonatal or early infant outcomes  

Next Post

Casirivimab and imdevimab reduced mortality in seronegative patients with COVID-19

RelatedReports

Late gestation antidepressant use linked to postpartum hemorrhage
Obstetrics

Monofilament suture does not reduce pregnancy loss compared to braided suture for cervical cerclage

December 13, 2022
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

Unintended pregnancy significantly associated with adverse maternal and infant health outcomes compared to intended pregnancy

November 8, 2022
Large proportion of late preterm infants and older admitted to the NICU
Obstetrics

Neonatal docosahexaenoic acid supplementation is associated with higher IQ scores at five years of age

October 31, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Obstetrics and Gynecology Classics

Magnesium for the prevention of cerebral palsy [Classics Series]

September 19, 2022
Next Post
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Casirivimab and imdevimab reduced mortality in seronegative patients with COVID-19

Single-cycle adjuvant chemotherapy may be effective in stage I testicular cancer

Chemotherapy not associated with an increased COVID-19 mortality risk in active cancer patients

Three-step support strategy reduces prolonged grief in relatives after death of intensive care unit patients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Similar perinatal outcomes observed amongst conception via natural and assisted reproductive means
  • Combination doxycycline and azithromycin therapy effective in treating severe scrub typhus
  • Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options